It's All About/Charity/Wichita/Researching Type 1 Diabetes
Type 1 diabetes (T1D) kills the body’s beta cells that produce insulin which gives us the energy we need for everyday life. JDRF’s vision, the Beta Cell Restoration Program, will not only stop the autoimmune attack but also return the number of beta cells to a normal level. JDRF is developing vaccines that will re-train the immune system to eliminate autoimmunity and leave the beta cells alone.
Type 1 diabetes (T1D) can occur in anyone—not just kids. If you or an adult you know has recently been diagnosed with T1D, check out the JDRF T1D Care Kit, a free resource containing information and tools to educate, support and inspire newly diagnosed adults. JDRF’s mission is to cure, treat and prevent type 1 diabetes!
– Urinating often;
– Feeling very thirsty;
– Feeling very hungry – even though you are eating;
– Extreme fatigue;
– Blurry vision;
– Cuts/bruises that are slow to heal;
– Weight loss – even though you are eating more (type 1);
– Tingling, pain, or numbness in the hands/feet (type 2). Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. People with T1D would never benefit from JDRF-funded innovations without our donors. The work to create transformational therapies to help people live with T1D cannot—and must not—be allowed to stop because dedicated researchers lack funds. Laboratory studies that are unlocking the mysteries of T1D and accelerating progress toward a cure and prevention must continue. With the generous help of supporters, JDRF is pursuing a diversified, dynamic research agenda that is moving us ever closer to a world without T1D.
JDRF is committed to doing the greatest good, for the largest number of people, in the shortest amount of time so we understand the importance of funding these trials. Today more than 50 human trials, studying life-changing drugs, treatments and devices, are under way with our support. That’s 10 times the number less than a decade ago! Here is a full list of video credits http://broadcaster.beazil.net/public/credits/youtube/videos/42350 The City of Wichita offers a number of incentive programs, including Industrial Revenue Bonds and a Neighborhood Revitalization Area Tax Rebate Program, which offers a 75- to 95-percent rebate on increased taxes due to new construction or refurbishment of property in certain areas within the city. The Wichita Business Loan Program has a loan pool of $9 million for existing and new small businesses within Revitalization Strategy Areas. The City of Wichita and the County of Sedgwick may extend tax exemptions for property used for manufacturing, research and development, or storing goods or commodities. Incentives offered by the Wichita Downtown Development Corp. include a Tenant Improvement Grant Fund, Housing and Pilot Landscaping grant programs, Douglas Street Facade Improvement Program, and Historic Preservation Tax Credits. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It seems important remind about the main points of that topic –
interstitial glucose,GDM,impaired glucose tolerance,SGLT2 inhibitors,Diabetes,Lee Ducat,subcutaneous injection,JDRF 2016,Kansas,Clinicians,Severe hypoglycemia,DPP,ASPIRE Trial,insulin-dependent diabetes mellitus,insulin independent remission,At Risk,A1C Test,care delivery systems,FPG value,EsTiD,diabetes diagnosis,precise,hyperglycemic crisis,diabetes mellitus,transplantation insulin-secreting cells,diabetes prevention program,Derek Rapp,insulin pen,insulin strength,JDRF Mentor Program,Somogyi effect,Pre- Diabetes,Insulin Pump Therapy,Oral Glucose Tolerance Test,diabetes management,glyburide,2-h plasma glucose,leading global organization,LADA,inhaled insulin,Scientific,Afrezza,insulin.